Eric Alejandro Sweet

Title: Eric Alejandro Sweet: Innovator in Ciliary Neurotrophic Factor Research

Introduction

Eric Alejandro Sweet is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biomedical research, particularly in the area of ciliary neurotrophic factor receptor (CNTFR) ligands. With a total of 2 patents, his work has the potential to impact treatments for cell proliferative disorders.

Latest Patents

Eric's latest patents include "Ciliary neurotrophic factor receptor ligand-binding agents and methods of using the same" and "Ciliary neurotrophic factor receptor ligands and methods of using the same." The first patent provides agents that specifically bind to a ligand of CNTFR, including a soluble CNTFR polypeptide with altered binding affinities. The second patent focuses on CNTFR ligands that exhibit increased affinity for CNTFR compared to wild-type ligands, along with methods for their use in pharmaceutical compositions.

Career Highlights

Eric works at Leland Stanford Junior University, where he continues to advance his research in neurobiology. His innovative approaches to understanding CNTFR signaling have positioned him as a key figure in his field.

Collaborations

Eric collaborates with esteemed colleagues such as Jun Woo Kim and Jennifer R Cochran. Their combined expertise enhances the research efforts at Leland Stanford Junior University.

Conclusion

Eric Alejandro Sweet is a prominent inventor whose work on CNTFR ligands holds promise for future medical advancements. His contributions to the field are noteworthy and reflect his dedication to innovation in biomedical research.